Welcome to our dedicated page for Lifemd news (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.
LifeMD, Inc. (LFMD) operates a leading telehealth platform connecting patients with HIPAA-compliant care solutions. This page serves as the definitive source for verified company news, providing investors and healthcare professionals with timely updates on key developments.
Access consolidated information on earnings reports, strategic partnerships, regulatory milestones, and service expansions. Our curated news collection simplifies tracking LFMD's progress in digital prescription services, remote diagnostics, and integrated telehealth solutions.
Discover updates across three core areas: financial performance announcements, operational developments in WorkSimpli software solutions, and advancements in secure patient-provider communication technologies. All content is sourced from official releases and trusted financial publications.
Bookmark this page for efficient monitoring of LifeMD's innovations in cloud-based pharmacy services, nutritional supplement offerings, and telehealth infrastructure. Return regularly to stay informed about this evolving leader in virtual healthcare delivery.
LifeMD, Inc. (NASDAQ: LFMD) has initiated an underwritten public offering of its common stock, with expectations to grant underwriters a 30-day option for additional shares. The company plans to use the net proceeds to reduce its debt and fund working capital, particularly for customer acquisition and capital expenditures. B. Riley Securities, Inc. is the lead manager for this offering, which is being conducted under an effective shelf registration statement. The press release emphasizes that this offering does not constitute an offer to sell securities in jurisdictions where it would be unlawful.
LifeMD, Inc. (NASDAQ: LFMD) has announced a public offering of 1,400,000 shares of Series A Cumulative Perpetual Preferred Stock, totaling a liquidation preference of $35 million. The offering includes a 30-day option for underwriters to purchase an additional 210,000 shares. Proceeds will be allocated to fund a segregated dividend account, repay a portion of debt, and for working capital including customer acquisition and capital expenditures. Book-running managers include B. Riley Securities and others, with the offering made under an effective shelf registration statement.
LifeMD, Inc. (NASDAQ: LFMD) has announced its participation in the Cantor Fitzgerald Virtual Global Healthcare Conference on September 30, 2021, at 12:40 PM ET. The telehealth company offers cash pay virtual medical treatments, prescription medications, and over-the-counter products to patients nationwide. Management will be available for virtual one-on-one meetings, with details accessible via a corporate contact link. LifeMD continues to expand its telemedicine platform to provide accessible healthcare solutions to patients across all 50 states.
LifeMD appoints Naveen Bhatia to its board of directors, enhancing its leadership as the company evolves in the telehealth sector. Bhatia, a seasoned investor with experience at Blackstone and various boards, brings significant financial and management expertise. His addition is expected to provide valuable insights and executional skills to LifeMD's growth strategy. The company aims to transform healthcare access for Americans through its telehealth platform, which focuses on delivering affordable, cash-pay virtual medical care nationwide.
LifeMD, a fast-growing telehealth company, announced its participation in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021. The event will feature virtual presentations and one-on-one investor meetings. LifeMD specializes in providing cash pay virtual medical treatments, prescription medications, and over-the-counter products to patients nationwide. The company's platform allows easy access to licensed medical professionals, enhancing patient convenience.
LifeMD, Inc. (NASDAQ: LFMD) announced a strategic partnership with Prescryptive Health, enhancing its telehealth capabilities. This collaboration will provide LifeMD with access to a nationwide pharmacy network and a digital pharmacy fulfillment platform. Key benefits include improved delivery times for prescriptions, expanded medication offerings, and the introduction of a prescription drug discount program. This initiative aims to strengthen LifeMD's position in the $500 billion U.S. prescription pharmacy market and enhance patient access to healthcare services.
LifeMD reported record revenue of $22.3 million for Q2 2021, marking a 145% increase year-over-year. 93% of revenue came from subscriptions, up from 56% last year. The total telehealth order volume grew by 155%, reaching 199,764 orders. Customer Acquisition Costs (CAC) decreased by 8% sequentially, while new patient acquisitions improved by 11%. Despite a net loss of $16.8 million, LifeMD reiterated its 2021 revenue guidance of $90 million to $100 million, signaling strong market demand and strategic growth initiatives.
LifeMD (NASDAQ: LFMD) announced a partnership with Particle Health to enhance personalized medical care through improved access to patient health records. With access to a database covering over 90% of the U.S. population, licensed providers can leverage comprehensive health data, paving the way for better healthcare outcomes. This strategic alliance aims to simplify healthcare delivery and strengthen patient-provider relationships, ultimately driving the launch of LifeMD's primary care platform.
LifeMD, Inc. (NASDAQ: LFMD) announced a conference call to discuss its second quarter fiscal 2021 financial results on August 12, 2021, at 4:30 p.m. ET. The results will be released prior to the call, and management will host the discussion followed by a Q&A session. LifeMD offers direct-to-patient telehealth services and products nationwide. The call can be accessed via toll-free and international dial-in numbers or streamed online. Interested parties should review the company's SEC filings for risk factors and historical financial data.
LifeMD (NASDAQ: LFMD) has partnered with Axle Health to provide telehealth access to over 150 diagnostic laboratory tests at preferred prices. Patients can complete tests securely in their homes or via local lab service centers. The collaboration aims to transform healthcare delivery by enhancing access to early diagnosis, which is crucial for effective healthcare outcomes. This integration is expected to improve patient services while supporting LifeMD's expansion in virtual primary care offerings.
